Results 1 to 10 of about 89 (85)

Practical aspects of intracerebroventricular infusions of cerliponase alfa in patients with neuronal ceroid lipofuscinosis type 2

open access: yesRussian Journal of Child Neurology
Neuronal ceroid lipofuscinosis type 2 (CLN2 disease) is a rare, autosomal recessive neurodegenerative disorder caused by mutations in the TPP1 gene, which lead to a decrease or complete loss of lysosomal tripeptidyl peptidase 1 enzyme activity. The classic form of CLN2 disease typically manifests between the ages of 2 and 4 years. Over time, there is a
Svetlana V. Mikhaylova   +3 more
openaire   +1 more source

Atypical neuronal ceroid lipofuscinosis type 2 disease (CLN2): a case report

open access: yesArquivos de Neuro-Psiquiatria, 2023
Mariana Braga Valadão   +5 more
openaire   +1 more source

The neuronal ceroid lipofuscinosis type 2 – associated variants: An analysis of alterations in the TPP1 gene and genotype–phenotype correlation in Ukraine

open access: yesJIMD Reports
AbstractThe neuronal ceroid lipofuscinosis type 2 (CLN2) is a heterogeneous group of neurodegenerative lysosomal storage disorders caused by autosomal recessive inheritance of two pathogenic variants in trans in the TPP1 gene. Classical late‐infantile CLN2 disease has a very well‐defined natural history.
Nataliia Olkhovych   +11 more
openaire   +4 more sources

Efficacy and Safety of Cerliponase Alpha Therapy in Neuronal Ceroid Lipofuscinosis Type 2

open access: yes, 2022
Serdaroğlu, Esra   +13 more
openaire   +1 more source

First case of use of cerliponase alfa in a child with neuronal ceroid lipofuscinosis type 2 in Bahia

open access: yesArquivos de Neuro-Psiquiatria
Érica Otoni Pereira Miranda   +8 more
openaire   +1 more source

Neuronal ceroid lipofuscinosis type 2 disease in a 4-year-old child with epilepsy and concerns for stuttering

open access: yesBrain and Development Case Reports
Lorena Galvan   +3 more
openaire   +1 more source
Some of the next articles are maybe not open access.

Photosensitivity Is an Early Marker of Neuronal Ceroid Lipofuscinosis Type 2 Disease

Epilepsia, 2017
SummaryObjectiveThis study aimed to identify early clinical, magnetic resonance imaging (MRI), and electroencephalographic (EEG) characteristics of neuronal ceroid lipofuscinosis type 2 (CLN2) disease to enable early diagnosis, thus providing the key to early treatment, and optimized care and outcomes.MethodsRetrospective clinical chart review of a ...
Federico Vigevano   +2 more
exaly   +3 more sources

Cynomolgus macaque model of neuronal ceroid lipofuscinosis type 2 disease

Experimental Neurology, 2023
Neuronal ceroid lipofuscinoses (NCLs) are autosomal-recessive fatal neurodegenerative diseases that occur in children and young adults, with symptoms including ataxia, seizures and visual impairment. We report the discovery of cynomolgus macaques carrying the CLN2/TPP1 variant and our analysis of whether the macaques could be a new non-human primate ...
Yoshiko, Munesue   +12 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy